PRPH - ProPhase Labs, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• ProPhase Labs eyes higher revenue for lozenge-making unit with improved pricing
• ProPhase hires Jed Latkin as COO
• ProPhase Labs reports Q3 results
• ProPhase Labs Q3 2023 Earnings Preview
• ProPhase Labs GAAP EPS of -$0.20 misses by $0.06, revenue of $13.22M misses by $0.92M
• ProPhase Labs Q2 2023 Earnings Preview
• ProPhase Labs says offer to buy Navidea assets rejected
• ProPhase Labs GAAP EPS of $0.03 beats by $0.13, revenue of $19.3M beats by $4.17M
• ProPhase Labs Q1 2023 Earnings Preview
• ProPhase Labs' Linebacker-1 cancer therapeutic shows promising mechanisms of actions
• ProPhase Labs GAAP EPS of $1.02 misses by $0.10, revenue of $122.65M beats by $1.31M
• ProPhase Labs Q4 2022 Earnings Preview
• ProPhase Labs launches $6M stock buyback plan
• ProPhase Labs GAAP EPS of $0.06 misses by $0.13, revenue of $24.2M beats by $2.77M
• ProPhase Labs Q3 2022 Earnings Preview
• ProPhase Labs GAAP EPS of $0.40 beats by $0.24, revenue of $29.09M beats by $5.77M
• ProPhase Labs Q2 2022 Earnings Preview
• ProPhase Labs announces $6M buyback plan
• DSS stock pops on licensing deal with ProPhase Labs
• ProPhase Labs to license two investigational cancer compounds from Global BioLife